Traded as LSE: CTEC Website www.convatec.com Revenue 1.65 billion USD (2015) Founded 1978 Type Public limited company | Industry Medical Devices Headquarters Deeside Founder E. R. Squibb Number of employees 9,000 | |
 | ||
Key people Sir Christopher Gent, Chairman
Paul Moraviec, CEO Products Wound and skin care, ostomy care, continence and critical care, infusion devices Operating income Subsidiaries 180 Medical, Inc., AbViser Medical, LLC | ||
ConvaTec Group plc is an international medical products and technologies company, offering products and services in the areas of wound and skin care, ostomy care, continence and critical care and infusion devices. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
Contents
History
The company was established as a division of E.R. Squibb & Sons, Inc. in 1978 and acquired by Nordic Capital and Avista Capital Partners in 2008. It acquired Unomedical, a manufacturer of single-use medical devices, in 2008 and 180 Medical, a catheter manufacturer, in 2012.
In June 2015 the company won a Court of Appeal ruling that rewrote the laws of mathematics in the patent context, holding the number one no longer has singular properties, but exists on a scale of 0.5 - 1.49. In October 2016 the company was valued at £4.4bn in the largest initial public offering on the London Stock Exchange in the year.
Operations
The company has 9,000 employees and operates in more than 100 countries.